Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
06/2011
06/08/2011CN102088961A Eprosartan compositions
06/08/2011CN102085372A Application of Notch pathway inhibitor in treatment of tumors caused by activation of mTOR
06/08/2011CN102085358A Application of medicament containing hirudin, hementerin and hyaluronidase
06/08/2011CN102085349A Preparation method and application of compound barbary wolfberry fruit preparation
06/08/2011CN102085322A Detection method of traditional Chinese medicine composition for treating hematuria
06/08/2011CN102085299A Chinese patent medicine for treating prostatitis and preparation method thereof
06/08/2011CN102085277A Medicament for treating benign prostatic hyperplasia and preparation method thereof
06/08/2011CN102085273A Extracting method of extractive for tonifying kidney and nourishing blood and medical composition thereof
06/08/2011CN102085253A Compound green vitriol capsule
06/08/2011CN102085232A Astragalus dispersible tablets
06/08/2011CN101816754B Orally-administered Chinese medicinal composition for treating acute gestational urinary infection
06/08/2011CN101658586B Medicament for treating male venereal disease and preparation method thereof
06/08/2011CN101596303B Pharmaceutical compound for curing prostatitis and prostate hyperplasia and preparation method and preparation thereof
06/08/2011CN101433653B Chinese medicinal composition for treating prostatitis and prostatoplasia
06/08/2011CN101406556B Chinese medicine preparation for treating acute prostatitis, prostatic hyperplasia and preparation method thereof
06/08/2011CN101317941B Medicament for promoting diuresis and easing pain
06/08/2011CN101080404B Pyrimidinylisoxazol derivative
06/07/2011US7956187 Method for decreasing opioid metabolism
06/07/2011US7956093 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins
06/07/2011CA2647932C Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound
06/07/2011CA2628607C Androgen synthesis inhibitors
06/07/2011CA2555824C Fused-ring 4-oxopyrimidine derivative
06/07/2011CA2490573C Improved transdermal delivery system
06/07/2011CA2435685C Desaturase genes and uses thereof
06/07/2011CA2418422C Novel kallikrein gene
06/07/2011CA2322954C Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
06/03/2011WO2011066006A2 Methods for treating aids
06/03/2011WO2011065519A1 Substituted oxopiperazine compound
06/03/2011WO2011064657A2 Quinazolin-4(3a)-one derivatives and methods of use thereof
06/02/2011US20110130454 Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof
06/02/2011US20110130436 Caspase inhibitors and uses thereof
06/02/2011US20110130424 Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
06/02/2011US20110130421 Methods and Compositions for the Treatment of Chronic Renal Hypertension
06/02/2011US20110130420 Isoquinolinone derivatives as nk3 antagonists
06/02/2011US20110130414 Novel fused thiazolo and oxazolo pyrimidinones
06/02/2011US20110130407 Isoquinolinone derivatives as nk3 antagonists
06/02/2011US20110130400 Trpv4 antagonists
06/02/2011US20110130376 New no releasing steroids derivatives
06/02/2011US20110130331 Modified growth hormones
06/02/2011US20110129463 Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof
06/01/2011EP2327775A2 Therapy for alpha-galactosidase a deficiency
06/01/2011EP2327418A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from other viruses
06/01/2011EP2327408A1 Tetracyclic cyclic gmp-specific phosphodiesterase inhibitors for the treatment of benign prostatic hypertrophy
06/01/2011EP2326668A1 Anti-il-12/il-23 antibodies
06/01/2011EP2326645A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it
06/01/2011EP2326644A1 Urotensin ii receptor antagonists
06/01/2011EP1584925B1 Novel screening method
06/01/2011EP1386608B1 Remedial agent for glomerular disease
06/01/2011CN102083810A Activator for peroxisome proliferator-activated receptor
06/01/2011CN102083787A Vinyl substituted fatty acids
06/01/2011CN102083437A Treatment of herpes virus related diseases
06/01/2011CN102079790A Recombination fusion protein PACAP-PTD (Pituitary Adenylate Cyclase Activating Peptide-Protein Transduction Domain) as well as expression method and application thereof
06/01/2011CN102079763A Dioxabicyclo-octane compound, preparation method and application thereof
06/01/2011CN102079750A Cefuroxime sodium compound and new preparation method thereof
06/01/2011CN102079746A Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors
06/01/2011CN102079743A Dipeptidyl peptidase inhibitors
06/01/2011CN102078608A Formulation of human antibodies for treating tnf-alpha associated disorders
06/01/2011CN102078585A Traditional Chinese medicine for treating kidney deficiency
06/01/2011CN102078578A Traditional Chinese medicine composition for treating enuresis due to spleen-lung vital energy deficiency
06/01/2011CN102078559A Chinese medicinal composition with functions of tonifying kidney and strengthening brain
06/01/2011CN102078557A Medicament for treating enuresis
06/01/2011CN102078553A Chinese medicine composition for treating liver meridian damp heat enuresis
06/01/2011CN102078552A Traditional Chinese medicine composition for treating enuresis due to kidney-qi asthenia cold
06/01/2011CN102078527A Traditional Chinese medicine formula for treating urinary calculus
06/01/2011CN102078505A Chinese herbal medicine for treating prostatitis
06/01/2011CN102078489A Traditional Chinese medicine preparation for non-gonococcal urethritis
06/01/2011CN102078485A Preparation method and application of compound dogwood preparation
06/01/2011CN102078483A Chinese patent medicine (Bezoar Qianliekang Turunda) for treating prostate disease and preparation method thereof
06/01/2011CN102078480A Nano element traditional Chinese medicine negative ion far infrared electromagnetic wave-resistant life prolonging medicinal liquor
06/01/2011CN102078476A Traditional Chinese medicine composition for treatment of chronic nephritis
06/01/2011CN102078440A Traditional Chinese medicine composition for kidney calculi
06/01/2011CN102078401A Traditional Chinese medicinal composition for treating chronic primary glomerulus diseases and application thereof
06/01/2011CN102078394A Aconite extract-containing medicinal composition, preparation method and application thereof
06/01/2011CN102078388A Traditional Chinese medicine composition for treating renal colic with upper urinary calculi
06/01/2011CN102078382A Traditional Chinese medicine decoction for treating difficult urination
06/01/2011CN101653569B Medicine for curing bladder neoplasm
06/01/2011CN101618051B Novel medicinal use of active parts of abelmoschus manihot general flavones
06/01/2011CN101468097B Chinese medicinal composition for nourishing liver and kidney, moistening intestines and relaxing piss, preparation and method for preparing the same
06/01/2011CN101416957B Use of resveratrol or naringenin in preventing and treating diabetic nephropathy
06/01/2011CN101361732B Medicinal preparation containing garcinia acid and use thereof
06/01/2011CN101341960B Concentrated tomato processing technique
06/01/2011CN101194991B Qi replenishing and spleen enlivening Chinese medicine
06/01/2011CN101099860B Use of erythropoietin
05/2011
05/31/2011US7951972 Human adam-10 inhibitors
05/31/2011CA2533515C Heteroaryl-tetrahydropyridyl compounds useful for treating or preventing pain
05/31/2011CA2483241C Novel diazabicyclononene derivatives
05/31/2011CA2475764C New inhibitors of histone deacetylase
05/31/2011CA2465750C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]-indole-1-carboxamide derivatives, their preparation and therapeutic use
05/31/2011CA2231772C Advanced glycation end-product intermediaries and post-amadori inhibition
05/26/2011WO2011062550A1 Benzoimidazole compounds and uses thereof
05/26/2011WO2011062437A2 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same
05/26/2011WO2011062194A1 Aminopyridine derivative
05/26/2011WO2011061330A2 Use of physiological cooling active ingredients, and agents containing such active ingredients
05/26/2011US20110126299 Triple transgenic mouse model of autoimmune disease and nf-kappa b in vivo imaging
05/26/2011US20110124695 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
05/26/2011US20110124680 Novel anthranilamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors
05/26/2011US20110124671 Spiroindenes and spiroindanes as modulators of chemokine receptors
05/26/2011US20110124658 Substituted oxindole derivatives and their use as vasopressin receptor ligands
05/26/2011US20110124657 Method for screening of 5ht7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter
05/26/2011US20110124642 Potassium channel modulators